DE69935522D1 - Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens während der natürlichen oder beschleunigten alterung (heliodermie, pollution) - Google Patents

Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens während der natürlichen oder beschleunigten alterung (heliodermie, pollution)

Info

Publication number
DE69935522D1
DE69935522D1 DE69935522T DE69935522T DE69935522D1 DE 69935522 D1 DE69935522 D1 DE 69935522D1 DE 69935522 T DE69935522 T DE 69935522T DE 69935522 T DE69935522 T DE 69935522T DE 69935522 D1 DE69935522 D1 DE 69935522D1
Authority
DE
Germany
Prior art keywords
heliodermie
dermopharmetic
hydratization
cosmetic
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935522T
Other languages
English (en)
Other versions
DE69935522T2 (de
Inventor
Karl Lintner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Publication of DE69935522D1 publication Critical patent/DE69935522D1/de
Application granted granted Critical
Publication of DE69935522T2 publication Critical patent/DE69935522T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69935522T 1998-09-15 1999-09-13 Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens bei der natürlichen oder beschleunigten alterung (heliodermie, umweltverschmutzung) Expired - Lifetime DE69935522T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9811533A FR2783169B1 (fr) 1998-09-15 1998-09-15 Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
FR9811533 1998-09-15
PCT/FR1999/002178 WO2000015188A1 (fr) 1998-09-15 1999-09-13 Utilisation cosmetique ou dermapharmaceutique de peptides pour la cicatrisation, l'hydratation et l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)

Publications (2)

Publication Number Publication Date
DE69935522D1 true DE69935522D1 (de) 2007-04-26
DE69935522T2 DE69935522T2 (de) 2007-12-13

Family

ID=9530478

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935522T Expired - Lifetime DE69935522T2 (de) 1998-09-15 1999-09-13 Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens bei der natürlichen oder beschleunigten alterung (heliodermie, umweltverschmutzung)

Country Status (8)

Country Link
US (1) US6620419B1 (de)
EP (1) EP1112057B1 (de)
JP (1) JP4572003B2 (de)
AU (1) AU5627999A (de)
DE (1) DE69935522T2 (de)
ES (1) ES2285859T3 (de)
FR (1) FR2783169B1 (de)
WO (1) WO2000015188A1 (de)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
FR2813018B1 (fr) * 2000-08-21 2004-02-06 Boots Co Plc Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2816511B1 (fr) * 2000-11-14 2003-08-08 Simon Thabaut Composition a base de methylsilanol hydroxyproline aspartate
FR2821086B1 (fr) * 2001-02-21 2003-12-12 Sederma Sa Procede de fabrication de proteines par fermentation de microorganismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetique les contenant
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
ES2387717T3 (es) 2001-02-28 2012-09-28 Johnson & Johnson Consumer Companies, Inc. Composiciones que contienen productos leguminosos
CA2441025C (en) * 2001-03-16 2011-08-16 Johnson & Johnson Consumer Companies, Inc. Composition containing feverfew extract and use thereof
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US6797697B2 (en) 2001-05-21 2004-09-28 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7081442B2 (en) 2001-05-21 2006-07-25 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7214655B2 (en) 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
ATE421877T1 (de) * 2001-09-17 2009-02-15 Johnson & Johnson Consumer Verwendung von totarol zur behandlung von pruritus
AU2002333155A1 (en) * 2001-10-30 2003-05-12 Pentapharm Ag Dermopharmaceutically and cosmetically active oligopeptides
US7041506B2 (en) 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
KR100753472B1 (ko) * 2002-03-15 2007-08-31 주식회사 엘지생활건강 사람 콜라겐 ⅰ형의 ｃ-말단에서 유래된 펩타이드에ｔａｔ 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물
AU2003220567A1 (en) * 2002-03-28 2003-10-13 Johnson And Johnson Consumer Companies, Inc. Compostions for darkening the skin
US7025951B2 (en) 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
FR2841781B1 (fr) * 2002-07-03 2005-12-16 Utilisation de peptides pour favoriser la regeneration cutannee
US6926886B2 (en) 2002-10-31 2005-08-09 Johnson & Johnson Consumer Companies, Inc. Compositions for darkening the skin and/or hair
US20040086471A1 (en) * 2002-10-31 2004-05-06 Lin Connie Baozhen Compositions for darkening the skin and/or hair
FR2848116B1 (fr) * 2002-12-10 2007-01-05 Nuxe Lab Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
FR2849375B1 (fr) * 2002-12-30 2006-10-20 Jean Noel Thorel Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
JP4249710B2 (ja) * 2002-12-30 2009-04-08 ジャン ノエル トレル、 皮膚代謝生理活性物質
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20050063932A1 (en) * 2003-08-14 2005-03-24 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US7220405B2 (en) 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US20050226839A1 (en) * 2003-09-08 2005-10-13 Xueying Huang Pepetide-based body surface reagents for personal care
US20100311641A1 (en) * 2003-09-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
EP1663118A4 (de) 2003-09-08 2008-10-15 Du Pont Konditionierer und färbemittel auf peptidbasis für haar, haut und nägel
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
WO2005048968A1 (en) 2003-11-17 2005-06-02 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
DE102004055541A1 (de) * 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
JP2006176431A (ja) * 2004-12-22 2006-07-06 Estate Chemical Kk 化粧料
FR2880627B1 (fr) * 2005-01-07 2007-05-18 Silab Sa Procede d'obtention d'un principe actif pour l'eclat du teint, principe actif obtenu et compositions associees
FR2880802B1 (fr) * 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US20070020220A1 (en) 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
KR20080005604A (ko) * 2005-06-06 2008-01-14 이엘씨 매니지먼트 엘엘씨 국소적 올리고펩타이드 전달 시스템
US7381707B2 (en) * 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
FR2890310B1 (fr) * 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
US20070065387A1 (en) * 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US7709601B2 (en) * 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7858581B2 (en) * 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US7928076B2 (en) * 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7700716B2 (en) * 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
US7632919B2 (en) * 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
EP1960421B1 (de) * 2005-12-15 2013-03-13 Sederma Neue polypeptide und deren verwendung
CA2634824A1 (en) 2005-12-23 2007-06-28 Nicolas Fasel Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
WO2007093839A1 (en) * 2006-02-16 2007-08-23 Sederma New polypeptides kxk and their use
TWI415628B (zh) 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
WO2007143006A2 (en) * 2006-06-01 2007-12-13 Therapeutic Peptides, Inc. Polymeric biosurfactants
US20080027212A1 (en) * 2006-06-28 2008-01-31 Skinner Keith K Methods and compositions for improved uptake of biological molecules
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
JP2010528981A (ja) 2006-12-01 2010-08-26 アンテリオス， インコーポレイテッド 両親媒性実体ナノ粒子
US20080311093A1 (en) * 2006-12-07 2008-12-18 American Symbolic, Llc Stem cell secretions and related methods
WO2008070868A1 (en) * 2006-12-07 2008-06-12 American Symbolic, Llc Stem cell secretions and related methods
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7678883B2 (en) 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US8383594B2 (en) * 2007-08-07 2013-02-26 Sami Labs Limited Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
US8273337B2 (en) 2007-09-14 2012-09-25 Affinergy Inc. Hair binding peptides and peptide-based hair reagents for personal care
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
EP2065029B1 (de) 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Körperpflege- und Kosmetikzusammensetzung mit Tetrapeptiden mit den Motiven GX1X2G, PX1X2P oder PX1X2K
CN102387772A (zh) * 2008-05-29 2012-03-21 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
WO2010050980A1 (en) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
EP2382231A2 (de) 2009-01-16 2011-11-02 Sederma Neue verbindungen, insbesondere peptide, zusammensetzungen damit und kosmetische und dermopharmazeutische verwendungen
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
US7915011B2 (en) * 2009-03-05 2011-03-29 E.I. Du Pont De Nemours And Company Host cell modifications that improve peptide production and downstream processing
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
FR2951081B1 (fr) 2009-10-14 2012-01-13 Cosmetique De Lecousse Lab Compostion dermatologique et/ou cosmetique utilisee pour la regeneration de la peau
FR2955326B1 (fr) 2010-01-18 2015-01-02 Sederma Sa Nouveau compose lipo-phosphate ou lipo-sulfate, compositions le contenant et utilisations cosmetiques et dermopharmaceutiques
FR2958541B1 (fr) 2010-04-08 2012-05-18 Sederma Sa Utilisation cosmetique du geranylgeranyl-2-propanol
FR2958641B1 (fr) 2010-04-08 2014-12-26 Sederma Sa Nouveaux composes de type polyterpenique, compositions cosmetiques, nutraceutiques et pharmaceutiques les contenant et utilisations dans ces domaines.
EP2382963A1 (de) 2010-04-29 2011-11-02 Cognis IP Management GmbH Kosmetische Zusammensetzung mit Oligopeptiden
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
JP6149279B2 (ja) 2011-02-09 2017-06-21 オーガノバランス ゲーエムベーハー 皮膚状態の治療に使用するためのペプチド
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
FR2974298B1 (fr) 2011-04-20 2013-11-29 Nuxe Lab Complexe d'extraits vegetaux pour la protection de la peau
WO2012145609A1 (en) 2011-04-21 2012-10-26 Sunny Biodiscovery, Inc. Transoral methods and compositions for wrinkle reduction and cosmetic lip and facial augmentation
EP2704706A1 (de) 2011-05-06 2014-03-12 Artskin D.O.O. Zusammensetzung mit einem angiotensin-ii-rezeptorantagonist und antioxidans zur bewahrung und/oder verbesserung von hauteigenschaften
MX358016B (es) * 2011-10-28 2018-08-02 Neostrata Company Inc Star Derivados de n-acildipeptido y sus usos.
MX2014008191A (es) * 2012-01-03 2015-03-19 Ruey J Yu Derivados de n-acilpeptido y sus usos.
US20140134217A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Leave-on compositions containing cellulose materials
US20140134218A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Rinse-off skin care compositions containing cellulosic materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
KR102276326B1 (ko) 2013-03-13 2021-07-13 앙테이스 에스.아. 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico
WO2015085421A1 (en) 2013-12-10 2015-06-18 Sussex Research Laboratories Inc. Glycopeptide compositions and uses thereof
US11160745B2 (en) 2014-04-18 2021-11-02 Gregory P. Pilant Methods and compositions for topical delivery for skin care
FR3027518B1 (fr) 2014-10-24 2018-01-19 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation d'ester d'isosorbide et de derives n-acyles d'acides amines comme agent antivieillissement de la peau humaine
FR3027599A1 (fr) 2014-10-27 2016-04-29 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Utilisation d'ester de derives n-acyles d'acide amines et de polyols comme agent antivieillissement de la peau humaine
EP3253400B1 (de) 2015-02-05 2023-01-18 Muhammed Majeed Oleanoylpeptidzusammensetzung
CA3018561A1 (en) 2016-03-21 2017-09-28 Rhode Island Council On Postsecondary Education Ph-sensitive peptides
FR3052978B1 (fr) 2016-06-23 2020-01-31 Biotechmarine Procede d'obtention d'un extrait d'armeria maritima enrichi en diglycosides et son utilisation en cosmetique
CN110198703A (zh) 2016-11-21 2019-09-03 艾里奥治疗公司 大试剂的透皮递送
KR102007078B1 (ko) 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
KR102056520B1 (ko) 2017-03-24 2019-12-18 (주)셀아이콘랩 인간 섬유아세포에서 콜라겐 합성 촉진 및 콜라겐 분해 효소 활성화 억제를 유도하는 펩타이드를 함유한 화장품 조성물 및 제조방법
JP7054954B2 (ja) * 2018-01-10 2022-04-15 ジー２ジーバイオ インコーポレイテッド コラーゲンペプチドを含有したポリカプロラクトン微粒球フィラーおよびその製造方法
ES2726000A1 (es) * 2018-03-28 2019-10-01 Infinitec Activos S L Nanopartículas de oro y palmitoíl pentapéptido-4
US20210121376A1 (en) 2018-05-22 2021-04-29 Infinitec Activos, S.L. Peptides encapsulated in lecithin and alginate
WO2020142211A1 (en) 2019-01-02 2020-07-09 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
EP3872088A1 (de) 2020-02-28 2021-09-01 Alganelle Verwendung von aprotinin als träger zum herstellen eines rekombinanten proteins, polypeptides oder peptids in algen
FR3107708A1 (fr) 2020-02-28 2021-09-03 Alganelle Microalgue recombinante capable de produire des peptides, polypeptides et protéines de KTTKS et leurs dérivés, et leurs procédé et utilisations associés
KR102378053B1 (ko) * 2020-12-24 2022-03-25 주식회사 조에바이오 유해물질 및 광에 대한 피부보호용 조성물
KR20230135586A (ko) 2021-01-24 2023-09-25 마이클 데이비드 포레스트 Atp 합성효소 억제제 - 미용 및 치료 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640943A (en) * 1983-09-22 1987-02-03 Ajinomoto Co., Inc. Surface modifier for inorganic substances
EP0420914B1 (de) * 1988-06-16 1994-03-09 Procyte Corporation Kosmetische und hautbehandlungs-zusammensetzungen
LU87449A1 (fr) * 1989-02-09 1990-09-19 Oreal Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
FR2676922B1 (fr) * 1991-06-03 1995-01-20 Givaudan Lavirotte Applications en cosmetique de derives n-acyles de melanges d'acides amines issus d'hydrolysats de proteines vegetales.

Also Published As

Publication number Publication date
EP1112057A1 (de) 2001-07-04
FR2783169B1 (fr) 2001-11-02
JP2002524487A (ja) 2002-08-06
AU5627999A (en) 2000-04-03
WO2000015188A1 (fr) 2000-03-23
FR2783169A1 (fr) 2000-03-17
EP1112057B1 (de) 2007-03-14
DE69935522T2 (de) 2007-12-13
ES2285859T3 (es) 2007-11-16
US6620419B1 (en) 2003-09-16
JP4572003B2 (ja) 2010-10-27

Similar Documents

Publication Publication Date Title
DE69935522D1 (de) Kosmetische oder dermopharmazeutische verwendung von peptiden zur wundheilung, hydratisierung, verbesserung des hautaussehens während der natürlichen oder beschleunigten alterung (heliodermie, pollution)
IL95393A0 (en) Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
DE69401230D1 (de) Verwendung von Polyurethanen, die funktionelle Carboxylatogruppe enthalt, zur Haarfestigung
DE69326125T2 (de) System zur Anwendung von Knoten in chirurgischem Nahtmaterial
DE69219418T2 (de) Zusammensetzung zur Revitalisierung von Nerbgewebe
DE69324689D1 (de) Verwendung von diacylglycerolen zur steigerung des melaningehaltes in melanozyten
DE60124989D1 (de) Verwendung eines Haarkosmetischen Mittels zur Reparatur oder zur Vorbeugung von porösen Haar
GB8304151D0 (en) Composition for treating hair skin/nails
ATE235887T1 (de) Verwendung von wässerigen arzneimittelzubereitungen zur erzeugung treibgasfreier aerosole
ATE223431T1 (de) Derivate von dolastatin, dreen herstellung un verwendung
DE69716189T2 (de) Verwendung von Melatonin-Derivaten zur Hautdepigmentierung sowie diese enthaltende Präparate
DE69720822D1 (de) Verwendung von Sprachaktivitätserkennung zur effizienten Sprachkodierung
DE69526935D1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69617963T2 (de) Behandlung von titandioxidaufachlämmungen mittels scherkräften
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69807454D1 (de) Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden
DE69400727D1 (de) Verwendung von 4-Thiuoresorcin-Derivaten in kosmetischen oder dermopharmazeutischen Zusammensetzungen zur Hautdepigmentierung
DE69732092D1 (de) Verwendung von inhibitoren der retinsäurewirkung zur wundheilung
DE69734464D1 (de) Verfahren zur expression und herstellung von rekombinantem, menschlichem beta-cis-interferon
DK0663796T3 (da) Collagenpølseskind med højt fugtighedsindhold
DE69716453D1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE9411835U1 (de) Behandeltes Natur- oder Kunsthaar zur Verwendung bei der Verlängerung oder Verstärkung von menschlichem Haar
DE69629027D1 (de) Kosmetische zubereitung zur prävention und beseitigung von hautschäden
DE69204658T2 (de) Kosmetische Zusammensetzung zur Haarbehandlung.
DE3886247D1 (de) Verwendung eines Haarkosmetischen Mittels zur vorbeugung von gesplissenem Haar oder gebrochenem Haar und zur Behandlung von beschädigtem Haar.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition